Prognostic Significance of Intratumoral Blood Vessel Invasion in Pathologic Stage IA Non-Small Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 89, Issue 3, 2010, Pages 864-869

  Shoji, Fumihiro ^a   Haro, Akira ^a   Yoshida, Tsukihisa ^a   Ito, Kensaku ^a   Morodomi, Yosuke ^a   Yano, Tokujiro ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE;

EID: 76749116630     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.09.047     Document Type: Article

References (20)

1. Asamura H., Goya T., Koshiishi Y., et al. A Japanese lung registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 3 (2008) 46-52
2. Goldstein N.S., Mani A., Chmielewski G., Welsh R., and Pursel S. Prognostic factors in T1N0M0 adenocarcinomas and bronchioloalveolar carcinomas of the lung. Am J Clin Pathol 112 (1999) 391-402
3. Tsuchiya T., Akamine S., Muraoka M., et al. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer 56 (2007) 341-348
4. Port J.L., Kent M.S., Korst R.J., Libby D., Pasmantier M., and Altorki N.K. Tumor size predicts survival within stage IA non-small cell lung cancer. Chest 124 (2003) 1828-1833
5. Gajra A., Newman N., Gamble G.P., Abraham N.Z., Kohman L.J., and Graziano S.L. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 42 (2003) 51-57
6. Christian C., Erica S., and Uliano M. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification. Lung Cancer 54 (2006) 185-191
7. Chang M.Y., Mentzer S.J., Colson Y.L., et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 134 (2007) 850-856
8. Rami-Porta R., Ball D., Crowly J., et al. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 593-602
9. Pignon J.P., Tribodet H., Scagliotti G.V., et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. J Clin Oncol 26 (2008) 3552-3559
10. Kato H., Ichinose Y., Ohta M., et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350 (2004) 1713-1721
11. Varlotto J.M., Recht A., Flickinger J.C., Medford-Davis L.N., Dyer A.M., and DeCamp M.M. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer 115 (2009) 1059-1069
12. International Union Against Cancer. TNM classification of malignant tumors. 5th ed. (1997), John Wiley & Sons, New York
13. The Japan Lung Cancer Society. General Rule for Clinical and Pathological Record of Lung Cancer [in Japanese]. 6th ed. (2003), Kanehara Publishing, Tokyo
14. Macchiarini P., Fontanini G., Harbin M.J., et al. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1N0Mo non-small-cell lung cancer. J Thorac Cardiovasc Surg 106 (1993) 80-89
15. Ogawa J., Tsurumi T., Yamada S., Koike S., and Shotsu A. Blood vessel invasion and expression od sialyl lewis and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Cancer 73 (1994) 1177-1183
16. Ichinose Y., Yano T., Asoh H., Yokoyama H., Yoshino I., and Katsuda Y. Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg 110 (1995) 601-605
17. Harpole Jr. D.H., Herndon II J.E., Young Jr. W.G., Wolfe W.G., and Sabiston D.C. Stage I nonsmall cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer 76 (1995) 787-796
18. Suzuki K., Nagai K., Yoshida J., et al. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. Cancer 86 (1999) 1976-1984
19. Pister K.M., Evans W.K., Azzoli C.G., et al. Cancer care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non-small-cell lung cancer guideline. J Clin Oncol 25 (2007) 5506-5518
20. Bodendorf M.O., Haas V., Laberke H.G., Blumenstock G., Wex P., and Graeter T. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma. Lung Cancer 64 (2009) 71-78